Effects of Intermittent Fasting on Health, Aging, and Disease | NEJM
Review Article from The New England Journal of Medicine — Effects of Intermittent Fasting on Health, Aging, and Disease
Related Articles
New bispecific antibodies in diffuse large B-cell lymphoma
CD20xCD3 T-cell-engaging bispecific antibodies are a highly active new treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Epcoritamab and glofitamab…
New bispecific antibodies in diffuse large B-cell lymphoma
CD20xCD3 T-cell-engaging bispecific antibodies are a highly active new treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Epcoritamab and glofitamab…
New bispecific antibodies in diffuse large B-cell lymphoma
CD20xCD3 T-cell-engaging bispecific antibodies are a highly active new treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Epcoritamab and glofitamab…
Sanidad fija el calendario de estancias de extranjeros en el SNS en 2026
Las solicitudes se podrán presentar a partir del 1 de septiembre y la permanencia formativa durará, como mucho, un año
MESA DEBATE “CLAVES en Linfoma del Manto” ICML Lugano 25 #CLAVESenLCM
Moderadores:Dr. Raúl Córdoba Mascuñano. Hospital Universitario Fundación Jiménez Díaz, MadridDra. Ana Marín-Niebla. Hospital Universitario Vall d´Hebron, Bar…
El plan del NHS inglés para la próxima década: ‘Reformarse o morir’
En un plan que describen como “una ruptura con el pasado”, los responsables del sistema sanitario proponen dar un giro a la gestión del NHS…
Bispecific antibodies in follicular lymphoma
Bispecific antibodies, specifically anti-CD20 T-cell engaging constructs, are poised to alter the treatment paradigm for multiple B-cell malignancies, including follicular lymphoma. Two CD20xCD3 bispecific antibodies,…
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukemia
Care for patients with chronic lymphocytic leukemia has been revolutionized in the last decade as Bruton tyrosine kinase inhibitors and the B-cell lymphoma
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.
Key Points. Prior exposure to CPI is associated with increased PFS due to decreased incidence of relapse after HCT, suggesting an increased GVL.PTCy based
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
Key PointsOur results indicate that ASCT is a curative option for patients with chemosensitive disease especially in CR after salvage.ASCT could still be c